The three most common genitourinary malignancies (prostate/kidney/bladder cancers)
constitute a substantial proportion of all cancer cases, mainly in the elderly population. Early …

Bladder cancer is the 9th leading cause of cancer death worldwide. The major problem in
bladder cancer is primarily the high recurrence rate after drug treatment and resection …

Background Bladder cancer accounts for the most common type of urologic malignancy and
presents high recurrence rate after surgical resection and adjuvant intravesical therapy. We …

Simple Summary Early detection of renal cell carcinoma (RCC) significantly increases the
likelihood of curative treatment, avoiding the need of adjuvant therapies, associated side …

MicroRNAs (miRNAs) can be secreted into body fluids and have thus been reported as a
new type of cancer biomarker. This study aimed to determine whether urinary miRNAs act as …

Background Bladder cancer (BC) is the tenth most common cancer in the world. Serum
microRNA (miRNA) profiles previously have been reported as non-invasive biomarkers in …

Background: Urinary bladder cancer (BCa) is globally the 10th most frequent cancer. As a
novel diagnostic tool, miRNA in serum screening is non-invasive. This project aimed to …

Background: Bladder cancer is one of the most prevalent malignancies. Due to the
disadvantage of existing bladder cancer diagnostic tools, miRNAs hold promise as new …

The purpose of this study is to clinically validate a series of circulating miRNAs that
distinguish between the 4 most prevalent tumor types (lung cancer (LC); breast cancer (BC); …

Purpose This study aimed to identify a diagnostic panel of serum microRNAs (miRNAs) for
the early detection of bladder cancer (BC). Methods Serum samples were collected from 112 …